U.S. flag

An official website of the United States government

NM_000179.3(MSH6):c.2398G>C (p.Val800Leu) AND Carcinoma of colon

Germline classification:
Likely benign (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001353412.9

Allele description [Variation Report for NM_000179.3(MSH6):c.2398G>C (p.Val800Leu)]

NM_000179.3(MSH6):c.2398G>C (p.Val800Leu)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.2398G>C (p.Val800Leu)
Other names:
p.V800L:GTT>CTT
HGVS:
  • NC_000002.12:g.47800381G>C
  • NG_007111.1:g.22235G>C
  • NM_000179.3:c.2398G>CMANE SELECT
  • NM_001281492.2:c.2008G>C
  • NM_001281493.2:c.1492G>C
  • NM_001281494.2:c.1492G>C
  • NP_000170.1:p.Val800Leu
  • NP_000170.1:p.Val800Leu
  • NP_001268421.1:p.Val670Leu
  • NP_001268422.1:p.Val498Leu
  • NP_001268423.1:p.Val498Leu
  • LRG_219t1:c.2398G>C
  • LRG_219:g.22235G>C
  • LRG_219p1:p.Val800Leu
  • NC_000002.11:g.48027520G>C
  • NM_000179.2:c.2398G>C
  • P52701:p.Val800Leu
  • p.V800L
Protein change:
V498L
Links:
UniProtKB: P52701#VAR_012961; dbSNP: rs61748083
NCBI 1000 Genomes Browser:
rs61748083
Molecular consequence:
  • NM_000179.3:c.2398G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281492.2:c.2008G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281493.2:c.1492G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281494.2:c.1492G>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Carcinoma of colon (CRC)
Synonyms:
Colonic carcinoma; Colon carcinoma
Identifiers:
MONDO: MONDO:0002032; MedGen: C0699790

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000592608Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Likely benignunknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyes1not providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV000592608.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

The MSH6 p.Val800Leu variant was identified in 1 of 558 proband chromosomes (frequency 0.002) from individuals with colorectal cancer (Kim 2004, Kolodner 1999) and was identified in 1 of 1038 control chromosomes (frequency 0.001) from these studies, increasing the likelihood that this may be a low frequency polymorphism. This variant was also identified in dbSNP (ID# rs61748083) “with untested allele”, in the Exome Variant Server ESP Project with a frequency of 0.0002 in European American alleles, and in the HGMD, MutDB, MMR DB, and InSIGHT Colon Cancer databases. The p.Val800 residue is not conserved in mammals and lower organisms, and computational analyses (PolyPhen2, SIFT, AlignGVGD, BLOSUM) do not suggest a high likelihood of impact to the protein. In addition, two in silico studies which assessed the impact of the variant on protein structure and function predicted this variant was neutral (Ali 2012, Terui 2013). However, this information is not predictive enough to rule out pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as predicted benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Nov 10, 2024